Andrew Mackinnon, executive GM, Medable, explains how the company ensures high patient participation and data accuracy in ...

DCT approaches in Japan typically involve partnerships among multiple satellite hospitals. Three main models aim to boost ...

Sui is an innovative Layer 1 blockchain and smart contract platform designed for fast, private, secure, and accessible digital asset ownership. Canary Capitals Bold Move: First Sui ETF Filed Canary ...

Now, AI generates potential treatments in record time—but the approval process hasn’t caught up. Regulatory agencies like the FDA, EMA, and PMDA struggle to ... Federated Learning: Train AI on ...

A European Medicines Agency committee, on Thursday, accepted the use of an artificial intelligence (AI) tool called AIM-NASH ...

PathAI, a global leader in AI-powered pathology, today announced that the European Medicines Agency (EMA) Committee for Medicinal Products for Human Use (CHMP) has granted full qualification for ...

When comparing the FDA and EMA, we found that many of the calculations that determine this relative speed have used time of approval and time of market authorization, interchangeably. This ...

Pfizer Inc. (NYSE:PFE) announced today that the U.S. Food and Drug Administration (FDA) has granted Priority Review for the ...

HTA as described by the HTA Regulation is the multidisciplinary scientific evidence-based process that allows to determine the relative effectiveness of new or existing health technologies. HTA is a ...

Fostering dialogue between neurologists, researchers, patient representatives, and policymakers is an important step towards ...